|
ISCU expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62447832963153E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
1.82920012470333E-10 |
| Normal-vs-Stage3 |
1.94289029309402E-13 |
| Normal-vs-Stage4 |
1.08890000349859E-08 |
| Stage1-vs-Stage2 |
6.034000E-01 |
| Stage1-vs-Stage3 |
3.653400E-01 |
| Stage1-vs-Stage4 |
5.552000E-01 |
| Stage2-vs-Stage3 |
2.749200E-01 |
| Stage2-vs-Stage4 |
3.703200E-01 |
| Stage3-vs-Stage4 |
9.282600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
4.61860000000591E-06 |
| Normal-vs-Asian |
6.80455691792758E-12 |
| Caucasian-vs-AfricanAmerican |
6.746800E-01 |
| Caucasian-vs-Asian |
2.551600E-01 |
| AfricanAmerican-vs-Asian |
6.806400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.7715611723761E-16 |
| Normal-vs-Female |
<1E-12 |
| Male-vs-Female |
1.250430E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
<1E-12 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
2.56017429478561E-12 |
| Normal-vs-Age(81-100Yrs) |
1.104380E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.361800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.659000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.101400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.401700E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.200800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.891600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.104000E-01 |
| Classical-VS-Follicular |
3.807000E-01 |
| Classical-VS-Other |
4.077000E-01 |
| Classical-VS-Normal |
1.62447832963153E-12 |
| Tall-VS-Follicular |
3.335200E-01 |
| Tall-VS-Other |
6.838200E-01 |
| Tall-VS-Normal |
4.61620000002938E-06 |
| Follicular-VS-Other |
3.917400E-01 |
| Follicular-VS-Normal |
9.779954623923E-13 |
| Other-VS-Normal |
1.264640E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.11022302462516E-16 |
| Normal-vs-N1 |
6.56359999684497E-08 |
| N0-vs-N1 |
5.669800E-01 |
|
|
